Validation of an in vitro model of progressive fibrosis that mimics Idiopathic Pulmonary Fibrosis
NIH U01HL153000Feb 15, 2021 - Jan 31, 2025
Role: Principal Investigator |
Targeting DNA Damage Repair Pathways to Reduce SARS-CoV-2 Replication in the Airways
Department of Defense PR202868Feb 1, 2021 - Jan 31, 2025
Role: Principle Investigator
Description: The goal is to repurpose a drug for COVID-19 by testing toxicity and efficacy in in vitro and in vivo lung smoking models. |
Translational models for drug discovery for IPF
Three Lakes Foundation CurePF-Translational Models for Pulmonary FibrosisJan 1, 2021 - Jan 1, 2024
Description: The goal is o develop novel models of Idiopathic Pulmonary Fibrosis and develop them for drug screening |
Understanding the effects of e-cigarettes on airway epithelial repair and homeostasis
UCOP-Tobacco-Related Disease Research Program T31IR1637Aug 1, 2020 - Jul 31, 2023
Description: The goal is to develop an aerosolized toxicity screen to test e-cigarette components to inform FDA regulation of different e-cigarette products |
| Burroughs Wellcome Fund 1020030Sep 1, 2019 - Aug 30, 2024 |
Increasing our understanding of airway basal stem cells and their function
Cystic Fibrosis Foundation Stem Cell ConsortiumMar 1, 2018 - Feb 28, 2024
Description: The goal is to understand basal stem cells in healthy and CF airway with a long-term view towards cell therapies. |
Developing a targeted chemoprevention strategy for Non-Small Cell Lung Cancer
NIH R01CA208303Aug 15, 2016 - Jul 31, 2021
Role: Principal Investigator |
Development of a High-Throughput Screen for Pre-therapeutic Discovery in Idiopathic Pulmonary Fibrosis
NIH R01GM114259Mar 1, 2015 - Feb 28, 2019
Role: Principal Investigator |
Progenitor Cells in Airway Repair
NIH R01HL094561Sep 1, 2009 - Jul 31, 2015
Role: Principal Investigator |
Cytokine Regulation of the Pulmonary Epithelium
NIH K08HL074229Dec 15, 2004 - Nov 30, 2009
Role: Principal Investigator |